Acorda Therapeutics reported $167.03M in Debt for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Acorda Therapeutics ACOR:US USD 167.03M 20.66M
Amgen AMGN:US USD 38.94B 241M
Aptinyx Inc APTX:US USD 24.71M 211K
Biogen BIIB:US USD 6.28B 1.8M
Biomarin Pharmaceutical BMRN:US USD 1.09B 3.46M
Clovis Oncology CLVS:US USD 660.38M 13.49M
Cytokinetics CYTK:US USD 611.62M 888K
Enanta Pharmaceuticals ENTA:US USD 1.42M 0
GlaxoSmithKline GSK:LN GBP 20.99B 1.13B
Halozyme Therapeutics HALO:US USD 1.51B 1.63M
Heron Therapeutics HRTX:US USD 149.23M 52K
Insmed INSM:US USD 1.16B 348.29M
Ligand Pharmaceuticals LGND:US USD 76.74M 92K
Mannkind MNKD:US USD 377.57M 540K
Merck MRK:GR EUR 10.4B 622M
Moderna Inc MRNA:US USD 1.07B 73M
Neurocrine Biosciences NBIX:US USD 169.4M 200K
Novartis NOVN:VX USD 27.91B 530M
Teva Pharmaceutical TEVA:IT USD 21.21B 54M
Vertex Pharmaceuticals VRTX:US USD 471.6M 29.3M